Vision and Mission

As a leading technology powered, innovation-driven company, HiGlance is growing as a research-driven, global healthcare company with a strong matrix of capabilities along the pharmaceutical value chain. Focusing on unmet medical needs such as antibacterial, antibiotic, cardiac, diabetes, inflammatory diseases etc., we are engaged in Discovering and developing innovative therapies for many of the world's unmet medical needs and offering these novel therapies on a platform of affordable innovation.

 

Media Gallery

News & Events


- HiGlance Laboratories designed Calcium combination with a unique new technology called "Dispersion Technology", which ensures early absorption & faster dissolution with delicious orange flavor.

- HiGlance Laboratories entered into Cardio & Diabetic segment with the launch of "CD Care" division to cater millions of people suffering from Cardio & Diabetes diseases.

- HiGlance Laboratories is partcipated(one of the major sponsor) in Research Society for the Study of Diabetes in India (RSSDI 2019) at Jaipur, Endocrine Society of India (ESICON) 2019 at Nagpur, Cardiological Society of India (CSICON 2019) at New Delhi, Association of Physicians of India (APICON 2020) at Agra .

- HiGlance Started their New Production facility for soft Gelatin Capsules.

- HiGlance entered into liquid oral segment and already started commercial production. Our product range includes Antibiotics, Antipyretic, Anti-inflammatory, Analgesic, Ant allergy, Cough Preparations, Multivitamins etc.

- HiGlance entered in chain pharmacy segment & started catering to millions of people in India.

.

Stockist